How should a 12-year-old female with a one-year history of bilateral axillary lymphadenopathy, who is otherwise well and has no B symptoms, be evaluated?

Evaluation of a 12-Year-Old Female with Bilateral Axillary Lymphadenopathy for One Year

In a well-appearing 12-year-old with chronic bilateral axillary lymphadenopathy and no B symptoms, initial evaluation should begin with axillary ultrasound, followed by targeted laboratory testing including complete blood count, inflammatory markers (ESR/CRP), and tuberculosis screening, with biopsy reserved for nodes that persist beyond 4 weeks of observation, demonstrate concerning sonographic features, or are associated with systemic symptoms.

Initial Clinical Assessment

The key clinical features to document include:

• Node characteristics: Size, consistency (soft vs. hard), mobility (mobile vs. matted/fused), and whether they are tender 1
• Duration and progression: One-year history suggests chronic process; assess if nodes are stable, enlarging, or fluctuating 1
• Systemic symptoms: Specifically document absence of fever, night sweats, unintentional weight loss, fatigue, or pruritus 1
• Infectious exposures: Recent upper respiratory infections, cat scratches, tick bites, tuberculosis contacts, and travel history 1
• Vaccination history: Recent immunizations (particularly COVID-19 vaccines) can cause axillary lymphadenopathy lasting over 100 days 2
• Medication and drug use history: Certain medications can cause lymphadenopathy 1

Imaging Approach

Ultrasound is the appropriate initial imaging modality for bilateral axillary lymphadenopathy in this pediatric patient 3. The ACR Appropriateness Criteria support ultrasound as the primary imaging tool for evaluating axillary masses, as it can differentiate solid from cystic lesions and characterize lymph node morphology 3.

Concerning Sonographic Features

Ultrasound should assess for features that may indicate malignancy or granulomatous disease:

• Loss of fatty hilum (present in 79.5% of benign cases in one study, so not specific) 4
• Cortical thickening (>3mm is concerning) 4, 5
• Round shape rather than oval (75.3% in benign cases) 4
• Marked hypoechogenicity (9.6% in benign cases) 4
• Size >2 cm 1
• Hard or matted/fused nodes on palpation suggest malignancy or granulomatous disease, particularly in children 1

Important caveat: In patients without known malignancy, suspicious sonographic features are frequently observed even in benign conditions, with combinations like round shape and loss of fatty hilum occurring in 61.6% of benign cases 4.

Laboratory Evaluation

When lymphadenopathy persists beyond 4 weeks or is bilateral, obtain:

• Complete blood count with differential: To evaluate for leukemia, lymphoma, or infectious causes 1
• Inflammatory markers: ESR and CRP to assess for inflammatory or autoimmune conditions 1
• Tuberculosis testing: PPD or interferon-gamma release assay, given that tuberculosis can present as axillary lymphadenopathy 4, 6

Observation vs. Biopsy Decision

Observation is appropriate when:

• Nodes are soft, mobile, and <2 cm 1
• No systemic symptoms present 1
• Recent vaccination or infection history provides explanation 2
• In patients without known malignancy, short-term follow-up imaging (3-6 months) rather than immediate biopsy is recommended even with suspicious sonographic features 4

Biopsy is indicated when:

• Lymphadenopathy persists beyond 4 weeks without clear benign etiology 1
• Nodes are >2 cm, hard, or matted/fused 1
• Progressive enlargement on follow-up imaging 4, 2
• Epitrochlear or supraclavicular involvement (higher malignancy risk) 1
• Systemic symptoms develop 1

Biopsy Technique

If biopsy is needed, options include:

• Ultrasound-guided fine-needle aspiration: Least invasive, can provide cytology and culture 4, 6
• Ultrasound-guided core needle biopsy: Provides more tissue for histology 4
• Excisional biopsy: Reserved for cases where less invasive methods are non-diagnostic 6

In one study of 73 patients without malignancy, FNAC results were representative of final pathology in >95% of cases, suggesting excision biopsy can often be omitted if FNAC and culture are negative 6.

Differential Diagnosis in This Age Group

The bilateral nature and chronic course in a well-appearing child suggests:

• Benign reactive hyperplasia (most common, 61.6% in one series) 4
• Infectious causes: Tuberculosis, atypical mycobacteria, cat-scratch disease 4, 6
• Autoimmune conditions: Juvenile idiopathic arthritis, systemic lupus erythematosus 6
• Kikuchi disease (histiocytic necrotizing lymphadenitis) 4
• Lymphoma or leukemia (less likely given chronic stable course and absence of B symptoms, but must be excluded) 1

Follow-Up Strategy

For this patient with one-year duration and no concerning features, perform ultrasound now and repeat in 3 months if nodes persist 4, 2. If nodes remain stable or decrease, continue observation. If nodes enlarge, develop concerning features, or systemic symptoms appear, proceed to biopsy 4.

Critical Pitfall to Avoid

Do not use corticosteroids empirically, as they can mask the histologic diagnosis of lymphoma or other malignancy 1. Antibiotics may be considered only if bacterial lymphadenitis is strongly suspected based on clinical features 1.